Takeda, TiGenix stem cell therapy shows sustained effect – FierceBiotech
FierceBiotech |
Takeda, TiGenix stem cell therapy shows sustained effect
FierceBiotech Takeda and TiGenix have presented 52-week data on their allogeneic expanded adipose-derived stem cells in Crohn's disease patients with treatment-refractory complex perianal fistulas. The data show the Cx601 stem cells continue to outperform placebo … Takeda and TiGenix Report New Data Highlighting Maintenance of Long-Term Remission of Complex Perianal … |
